Evidence map›Paper›PMID 25764981›Full record

ArticleBiochemical pharmacology2015

Pharmacological inhibition of ALDH1A in mice decreases all-trans retinoic acid concentrations in a tissue specific manner.

Samuel L M Arnold, Travis Kent, Cathryn A Hogarth, Michael D Griswold, John K Amory, Nina Isoherranen

Abstract read
In one paragraph

Article in Biochemical pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Aldehyde Oxidase Contributes to All-Drug metabolism and disposition: the biological fate of chemicals · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Samuel L M ArnoldDepartment of Pharmaceutics, University of Washington, Seattle, WA 98195, USA.
Travis KentSchool of Molecular Biosciences and The Center for Reproductive Biology, Washington State University, Pullman, WA 99164, USA.
Cathryn A HogarthSchool of Molecular Biosciences and The Center for Reproductive Biology, Washington State University, Pullman, WA 99164, USA.
Michael D GriswoldSchool of Molecular Biosciences and The Center for Reproductive Biology, Washington State University, Pullman, WA 99164, USA.
John K AmoryDepartment of Medicine, University of Washington, Seattle, WA 98195, USA.
Nina IsoherranenDepartment of Pharmaceutics, University of Washington, Seattle, WA 98195, USA. Electronic address: ni2@uw.edu.
University of Washington · USWashington State University · US

Funding

Spermatogonial Stem Cell Self-Renewal and DifferentiationU54HD042454 · NICHD · UNIVERSITY OF WASHINGTON · PI BREMNER, WILLIAM J · 2002 to 2016
$26.9M
Hormonal Regulation Sertoli Cell MaturationR01HD010808 · NICHD · WASHINGTON STATE UNIVERSITY · PI MICHAEL D GRISWOLD · 1985 to 2026
$6.0M
Mechanisms of Regulation of Retinoic Acid HomeostasisR01GM111772 · NIGMS · UNIVERSITY OF WASHINGTON · PI ISOHERRANEN, NINA · 2014 to 2021
$3.0M
Institute of Translational Health SciencesTL1TR000422 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$2.1M
Effects of Xenobiotics on CYP26 Activity and Retinoic Acid HomeostasisR01GM081569 · NIGMS · UNIVERSITY OF WASHINGTON · PI ISOHERRANEN, NINA · 2008 to 2012
$1.7M
Retinoic Acid in Male InfertilityK24HD082231 · NICHD · UNIVERSITY OF WASHINGTON · PI AMORY, JOHN K. · 2015 to 2019
$638k
NCATS NIH HHS TL1 TR000422NICHD NIH HHS K24 HD082231NICHD NIH HHS R01 HD010808NICHD NIH HHS U54 HD042454NICHD NIH HHS U54 HD42454NIGMS NIH HHS R01 GM081569NIGMS NIH HHS R01 GM-081569-S1NIGMS NIH HHS R01 GM10808NIGMS NIH HHS R01 GM111772
6 · The paper itself

Abstract

all-trans retinoic acid (atRA), the active metabolite of vitamin A, is an essential signaling molecule. Specifically the concentrations of atRA are spatiotemporally controlled in target tissues such as the liver and the testes. While the enzymes of the aldehyde dehydrogenase 1A family (ALDH1A) are believed to control the synthesis of atRA, a direct relationship between altered ALDH1A activity and tissue atRA concentrations has never been shown. To test whether inhibition of ALDH1A enzymes decreases atRA concentrations in a tissue specific manner, the potent ALDH1A inhibitor WIN 18,446 was used to inhibit ALDH1A activity in mice. The ALDH1A expression, atRA formation kinetics, ALDH1A inhibition by WIN 18,446 and WIN 18,446 disposition were used to predict the time course and extent of inhibition of atRA formation in the testis and liver. The effect of WIN 18,446 on atRA concentrations in testis, liver and serum were measured following single and multiple doses of WIN 18,446. ALDH1A1 and ALDH1A2 were responsible for the majority of atRA formation in the testis while ALDH1A1 and aldehyde oxidase contributed to atRA formation in the liver. Due to the different complement of enzymes contributing to atRA formation in different tissues and different inhibition of ALDH1A1 and ALDH1A2 by WIN 18,446, WIN 18,446 caused only a 50% decrease in liver atRA but testicular atRA decreased over 90%. Serum atRA concentrations were also reduced. These data demonstrate that inhibition of ALDH1A enzymes will decrease atRA concentrations in a tissue specific manner and selective ALDH1A inhibition could be used to alter atRA concentrations in select target tissues.

Indexed as

Aldehyde DehydrogenaseAldehyde Dehydrogenase 1 FamilyAmino Acid SequenceAnimalsMaleMass SpectrometryMiceMice, Inbred C57BLMolecular Sequence DataRetinal DehydrogenaseTissue DistributionTretinoinAldehyde DehydrogenaseAldehyde Dehydrogenase 1 FamilyALDH1A1 protein, mouseRetinal DehydrogenaseTretinoinAldehyde dehydrogenaseAldehyde oxidaseLiverMass spectrometryRetinoic acidTestes

Identifiers

PMID25764981
PMCPMC4420653
OpenAlexW2007538507

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.